siRNA targeting ANGPTL3 stands in the spotlight for lipid-lowering therapy

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

3 Citations (Scopus)

Original language	English
Pages (from-to)	369-370
Number of pages	2
Journal	Molecular Therapy Nucleic Acids
Volume	32
DOIs	https://doi.org/10.1016/j.omtn.2023.03.020
Publication status	Published - 13 Jun 2023

Access to Document

@article{1ccc1cf5cc3b48a29fbf6926b2173cfb,

title = "siRNA targeting ANGPTL3 stands in the spotlight for lipid-lowering therapy",

author = "Bo Hu and Yuanyu Huang",

year = "2023",

month = jun,

day = "13",

doi = "10.1016/j.omtn.2023.03.020",

language = "English",

volume = "32",

pages = "369--370",

journal = "Molecular Therapy Nucleic Acids",

issn = "2162-2531",

publisher = "Cell Press",

}

TY - JOUR

T1 - siRNA targeting ANGPTL3 stands in the spotlight for lipid-lowering therapy

AU - Hu, Bo

AU - Huang, Yuanyu

PY - 2023/6/13

Y1 - 2023/6/13

UR - http://www.scopus.com/inward/record.url?scp=85152743230&partnerID=8YFLogxK

U2 - 10.1016/j.omtn.2023.03.020

DO - 10.1016/j.omtn.2023.03.020

M3 - Comment/debate

AN - SCOPUS:85152743230

SN - 2162-2531

VL - 32

SP - 369

EP - 370

JO - Molecular Therapy Nucleic Acids

JF - Molecular Therapy Nucleic Acids

ER -